Lipid phosphate phosphatase (LPP3) and vascular development

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

Volumn 1831, Issue 1, 2013, Pages 126-132

  Ren, H ^a   Panchatcharam, M ^a   Mueller, P ^a   Escalante Alcalde, D ^b   Morris, A J ^a   Smyth, S S ^a,c  

^a UNIVERSITY OF KENTUCKY   (United States)

^b INSTITUTO DE FISIOLOGÍA CELULAR   (Mexico)

^c LEXINGTON VA MEDICAL CENTER   (United States)

Author keywords

Endothelial cell; Lysophosphatidic acid; Lysophospholipid; Sphingosine 1 phosphate; Vascular development

Indexed keywords

ADENYLATE CYCLASE; ANGIOPOIETIN RECEPTOR; AUTOTAXIN; GELATINASE A; LIPID PHOSPHATE PHOSPHATASE; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDATE PHOSPHATASE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOLIPASE C; SPHINGOSINE KINASE 1; SPHINGOSINE KINASE 2; UNCLASSIFIED DRUG; VASCULOTROPIN;

AMINO ACID SEQUENCE; ANGIOGENESIS; CANCER SURVIVAL; CARCINOGENESIS; CATALYSIS; CELL DIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION; COLONY FORMING UNIT; CORONARY ARTERY DISEASE; DIABETES MELLITUS; EMBRYO DEVELOPMENT; ENZYME PHOSPHORYLATION; EXON; GASTRULATION; GENE DELETION; GENE EXPRESSION; HEMATOPOIETIC CELL; HUMAN; HYDROLYSIS; HYPERTENSION; MOLECULAR DYNAMICS; NOMENCLATURE; NONHUMAN; OBESITY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION; THROMBOCYTE ACTIVATION; TUMOR GROWTH; VASCULARIZATION; VASODILATATION;

ANIMALS; BLOOD VESSELS; CARDIOVASCULAR DISEASES; HUMANS; LYSOPHOSPHOLIPIDS; PHOSPHATIDATE PHOSPHATASE; RECEPTORS, LYSOSPHINGOLIPID; SIGNAL TRANSDUCTION;

MAMMALIA; MUS;

EID: 84868570200     PISSN: 13881981     EISSN: 18792618     Source Type: Journal    
DOI: 10.1016/j.bbalip.2012.07.012     Document Type: Review

References (98)

1. V.A. Sciorra, and A.J. Morris Roles for lipid phosphate phosphatases in regulation of cellular signaling Biochim. Biophys. Acta 1582 2002 45 51
2. Y.J. Sigal, M.I. McDermott, and A.J. Morris Integral membrane lipid phosphatases/phosphotransferases: common structure and diverse functions Biochem. J. 387 2005 281 293
3. 2 +-independent phosphatidic acid phosphatase J. Biol. Chem. 272 1997 24572 24578
4. R. Roberts, V.A. Sciorra, and A.J. Morris Human type 2 phosphatidic acid phosphohydrolases. Substrate specificity of the type 2a, 2b, and 2c enzymes and cell surface activity of the 2a isoform J. Biol. Chem. 273 1998 22059 22067
5. J.S. Long, N.J. Pyne, and S. Pyne Lipid phosphate phosphatases form homo- and hetero-oligomers: catalytic competency, subcellular distribution and function Biochem. J. 411 2008 371 377
6. C. Burnett, P. Makridou, L. Hewlett, and K. Howard Lipid phosphate phosphatases dimerise, but this interaction is not required for in vivo activity BMC Biochem. 5 2004 2
7. D.N. Brindley, D. English, C. Pilquil, K. Buri, and Z.C. Ling Lipid phosphate phosphatases regulate signal transduction through glycerolipids and sphingolipids Biochim. Biophys. Acta Mol. Cell. Biol. Lipids 1582 2002 33 44
8. T. Ishikawa, M. Kai, I. Wada, and H. Kanoh Cell surface activities of the human type 2b phosphatidic acid phosphatase J. Biochem. 127 2000 645 651
9. M. Kai, F. Sakane, Y.J. Jia, S. Imai, S. Yasuda, and H. Kanoh Lipid phosphate phosphatases 1 and 3 are localized in distinct lipid rafts J. Biochem. 140 2006 677 686
10. J.L. Tomsig, A.H. Snyder, E.V. Berdyshev, A. Skobeleva, C. Mataya, V. Natarajan, D.N. Brindley, and K.R. Lynch Lipid phosphate phosphohydrolase type 1 (LPP1) degrades extracellular lysophosphatidic acid in vivo Biochem. J. 419 2009 611 618
11. A.J. Morris, S.S. Smyth, A. Salous, and A.D. Renault Lipid phosphate phosphatases: recent progress and assay methods Lysophospholipid Receptors: Signaling and Biochemistry 2012 John Wiley
12. D. Escalante-Alcalde, L. Hernandez, H. Le Stunff, R. Maeda, H.S. Lee, C. Jr Gang, V.A. Sciorra, I. Daar, S. Spiegel, A.J. Morris, and C.L. Stewart The lipid phosphatase LPP3 regulates extra-embryonic vasculogenesis and axis patterning Development 130 2003 4623 4637
13. D. Escalante-Alcalde, S.L. Morales, and C.L. Stewart Generation of a reporter-null allele of Ppap2b/Lpp 3 and its expression during embryogenesis Int. J. Dev. Biol. 53 2009 139 147
14. M. Panchatcharam, S. Miriyala, J. Wheeler, A.K. Salous, A. Dong, M. Sunkara, A.J. Morris, D. Escalante-Alcalde, and S.S. Smyth Mice with endothelial-targeted inactivation of Ppap2b (lipid phosphate phosphatase 3) display enhanced vascular inflammation Circulation 124 2011
15. K. Senda, K. Koizumi, O. Prangsaengtong, T. Minami, S. Suzuki, I. Takasaki, Y. Tabuchi, H. Sakurai, Y. Doki, T. Misaki, and I. Saiki Inducible capillary formation in lymphatic endothelial cells by blocking lipid phosphate phosphatase-3 activity Lymphat. Res. Biol. 7 2009 69 74
16. S. Pyne, J.S. Long, N.T. Ktistakis, and N.J. Pyne Lipid phosphate phosphatases and lipid phosphate signalling Biochem. Soc. Trans. 33 2005 1370 1374
17. D.N. Brindley, and C. Pilquil Lipid phosphate phosphatases and signaling J. Lipid Res. 50 2009 S225 S230 (Suppl.)
18. J.L. Tanyi, A.J. Morris, J.K. Wolf, X. Fang, Y. Hasegawa, R. Lapushin, N. Auersperg, Y.J. Sigal, R.A. Newman, E.A. Felix, E.N. Atkinson, and G.B. Mills The human lipid phosphate phosphatase-3 decreases the growth, survival, and tumorigenesis of ovarian cancer cells: validation of the lysophosphatidic acid signaling cascade as a target for therapy in ovarian cancer Cancer Res. 63 2003 1073 1082
19. M. Umezu-Goto, Y. Kishi, A. Taira, K. Hama, N. Dohmae, K. Takio, T. Yamori, G.B. Mills, K. Inoue, J. Aoki, and H. Arai Autotaxin has lysophospholipase D activity leading to tumor cell growth and motility by lysophosphatidic acid production J. Cell Biol. 158 2002 227 233
20. Z. Pamuklar, L. Federico, S. Liu, M. Umezu-Goto, A. Dong, M. Panchatcharam, Z. Fulkerson, E. Berdyshev, V. Natarajan, X. Fang, L.A. van Meeteren, W.H. Moolenaar, G.B. Mills, A.J. Morris, and S.S. Smyth Autotaxin/lysopholipase D and lysophosphatidic acid regulate murine hemostasis and thrombosis J. Biol. Chem. 284 2009 7385 7394
21. G.B. Mills, and W.H. Moolenaar The emerging role of lysophosphatidic acid in cancer Nat. Rev. Cancer 3 2003 582 591
22. D.L. Baker, P. Morrison, B. Miller, C.A. Riely, B. Tolley, A.M. Westermann, J.M. Bonfrer, E. Bais, W.H. Moolenaar, and G. Tigyi Plasma lysophosphatidic acid concentration and ovarian cancer JAMA 287 2002 3081 3082
23. M.Z. Cui Lysophosphatidic acid effects on atherosclerosis and thrombosis J. Clin. Lipidol. 6 2011 413 426
24. C. Gustin, M. Van Steenbrugge, and M. Raes LPA modulates monocyte migration directly and via LPA-stimulated endothelial cells Am. J. Physiol. Cell Physiol. 295 2008 C905 C914
25. M. Gomaraschi, G. Sinagra, L.V. Serdoz, C. Pitzorno, M. Fonda, L. Cattin, L. Calabresi, and G. Franceschini The plasma concentration of Lpa-I:A-II particles as a predictor of the inflammatory response in patients with ST-elevation myocardial infarction Atherosclerosis 202 2009 304 311
26. S. Koike, K. Keino-Masu, T. Ohto, F. Sugiyama, S. Takahashi, and M. Masu Autotaxin/lysophospholipase D-mediated lysophosphatidic acid signaling is required to form distinctive large lysosomes in the visceral endoderm cells of the mouse yolk sac J. Biol. Chem. 284 2009 33561 33570
27. S. Fotopoulou, N. Oikonomou, E. Grigorieva, I. Nikitopoulou, T. Paparountas, A. Thanassopoulou, Z. Zhao, Y. Xu, D.L. Kontoyiannis, E. Remboutsika, and V. Aidinis ATX expression and LPA signalling are vital for the development of the nervous system Dev. Biol. 339 2010 451 464
28. L.A. van Meeteren, P. Ruurs, C. Stortelers, P. Bouwman, M.A. van Rooijen, J.P. Pradere, T.R. Pettit, M.J.O. Wakelam, J.S. Saulnier-Blache, C.L. Mummery, W.H. Moolenaar, and J. Jonkers Autotaxin, a secreted lysophospholipase D, is essential for blood vessel formation during development Mol. Cell. Biol. 26 2006 5015 5022
29. G. Ferry, A. Giganti, F. Coge, F. Bertaux, K. Thiam, and J.A. Boutin Functional invalidation of the autotaxin gene by a single amino acid mutation in mouse is lethal FEBS Lett. 581 2007 3572 3578
30. A.L. Parrill Lysophospholipid interactions with protein targets Biochim. Biophys. Acta 1781 2008 540 546
31. S.M. Pasternack, I. von Kugelgen, K. Al Aboud, Y.A. Lee, F. Ruschendorf, K. Voss, A.M. Hillmer, G.J. Molderings, T. Franz, A. Ramirez, P. Nurnberg, M.M. Nothen, and R.C. Betz G protein-coupled receptor P2Y5 and its ligand LPA are involved in maintenance of human hair growth Nat. Genet. 40 2008 329 334
32. K. Tabata, K. Baba, A. Shiraishi, M. Ito, and N. Fujita The orphan GPCR GPR87 was deorphanized and shown to be a lysophosphatidic acid receptor Biochem. Biophys. Res. Commun. 363 2007 861 866
33. J.H. Hecht, J.A. Weiner, S.R. Post, and J. Chun Ventricular zone gene-1 (vzg-1) encodes a lysophosphatidic acid receptor expressed in neurogenic regions of the developing cerebral cortex J. Cell Biol. 135 1996 1071 1083
34. S. An, T. Bleu, O.G. Hallmark, and E.J. Goetzl Characterization of a novel subtype of human G protein-coupled receptor for lysophosphatidic acid J. Biol. Chem. 273 1998 7906 7910
35. K. Bandoh, J. Aoki, H. Hosono, S. Kobayashi, T. Kobayashi, K. Murakami-Murofushi, M. Tsujimoto, H. Arai, and K. Inoue Molecular cloning and characterization of a novel human G-protein-coupled receptor, EDG7, for lysophosphatidic acid J. Biol. Chem. 274 1999 27776 27785
36. D.S. Im, C.E. Heise, M.A. Harding, S.R. George, B.F. O'Dowd, D. Theodorescu, and K.R. Lynch Molecular cloning and characterization of a lysophosphatidic acid receptor, Edg-7, expressed in prostate Mol. Pharmacol. 57 2000 753 759
37. K. Noguchi, S. Ishii, and T. Shimizu Identification of p2y9/GPR23 as a novel G protein-coupled receptor for lysophosphatidic acid, structurally distant from the Edg family J. Biol. Chem. 278 2003 25600 25606
38. M. Murakami, A. Shiraishi, K. Tabata, and N. Fujita Identification of the orphan GPCR, P2Y(10) receptor as the sphingosine-1-phosphate and lysophosphatidic acid receptor Biochem. Biophys. Res. Commun. 371 2008 707 712
39. J. Radeff-Huang, T.M. Seasholtz, R.G. Matteo, and J.H. Brown G protein mediated signaling pathways in lysophospholipid induced cell proliferation and survival J. Cell. Biochem. 92 2004 949 966
40. D.N. Brindley, C. Pilquil, M. Sariahmetoglu, and K. Reue Phosphatidate degradation: phosphatidate phosphatases (lipins) and lipid phosphate phosphatases Biochim. Biophys. Acta 1791 2009 956 961
41. V. Rai, F. Touré, S. Chitayat, R. Pei, Y. Lu, Q. Li, R. Rosario, Z. Zhu, W. Qu, F. Song, R. Ramasamy, W.J. Chazin, and A.M. Schmidt Lysophosphatidic Acid Mediates Vascular Signaling via an Immunoglobulin Superfamily Receptor Arteriosclerosis, Thrombosis, and Vascular Biology 2011 68 American Heart Association, Chicago, IL
42. H. Sumida, K. Noguchi, Y. Kihara, M. Abe, K. Yanagida, F. Hamano, S. Sato, K. Tamaki, Y. Morishita, M.R. Kano, C. Iwata, K. Miyazono, K. Sakimura, T. Shimizu, and S. Ishii LPA4 regulates blood and lymphatic vessel formation during mouse embryogenesis Blood 116 2010 5060 5070
43. H. Yukiura, K. Hama, K. Nakanaga, M. Tanaka, Y. Asaoka, S. Okudaira, N. Arima, A. Inoue, T. Hashimoto, H. Arai, A. Kawahara, H. Nishina, and J. Aoki Autotaxin regulates vascular development via multiple lysophosphatidic acid (LPA) receptors in zebrafish J. Biol. Chem. 286 2011 43972 43983
44. D. English, A.T. Kovala, Z. Welch, K.A. Harvey, R.A. Siddiqui, D.N. Brindley, and J.G. Garcia Induction of endothelial cell chemotaxis by sphingosine 1-phosphate and stabilization of endothelial monolayer barrier function by lysophosphatidic acid, potential mediators of hematopoietic angiogenesis J. Hematother. Stem Cell Res. 8 1999 627 634
45. H. Lee, E.J. Goetzl, and S. An Lysophosphatidic acid and sphingosine 1-phosphate stimulate endothelial cell wound healing Am. J. Physiol. Cell Physiol. 278 2000 C612 C618
46. T.S. Panetti, and D.F. Mosher Lysophospholipid-induced cell migration Ann. N. Y. Acad. Sci. 905 2000 326 329
47. B. Ren, J. Hale, S. Srikanthan, and R.L. Silverstein Lysophosphatidic acid suppresses endothelial cell CD36 expression and promotes angiogenesis via a PKD-1-dependent signaling pathway Blood 117 2011 6036 6045
48. M. Tanaka, S. Okudaira, Y. Kishi, R. Ohkawa, S. Iseki, M. Ota, S. Noji, Y. Yatomi, J. Aoki, and H. Arai Autotaxin stabilizes blood vessels and is required for embryonic vasculature by producing lysophosphatidic acid J. Biol. Chem. 281 2006 25822 25830
49. W.T. Wu, C.N. Chen, C.I. Lin, J.H. Chen, and H. Lee Lysophospholipids enhance matrix metalloproteinase-2 expression in human endothelial cells Endocrinology 146 2005 3387 3400
50. Y. Song, J. Wu, R.A. Oyesanya, Z. Lee, A. Mukherjee, and X. Fang Sp-1 and c-Myc mediate lysophosphatidic acid-induced expression of vascular endothelial growth factor in ovarian cancer cells via a hypoxia-inducible factor-1-independent mechanism Clin. Cancer Res. 15 2009 492 501
51. E.H. Ahn, and J.J. Schroeder Induction of apoptosis by sphingosine, sphinganine, and C(2)-ceramide in human colon cancer cells, but not by C(2)-dihydroceramide Anticancer. Res. 30 2010 2881 2884
52. T. Moriue, J. Igarashi, K. Yoneda, K. Nakai, H. Kosaka, and Y. Kubota Sphingosine 1-phosphate attenuates H2O2-induced apoptosis in endothelial cells Biochem. Biophys. Res. Commun. 368 2008 852 857
53. Y.L. Huang, H.S. Lin, S.U. Chen, and H. Lee Tyrosine sulphation of sphingosine 1-phosphate 1 (S1P(1)) is required for S1P-mediated cell migration in primary cultures of human umbilical vein endothelial cells J. Biochem. 146 2009 815 820
54. D.A. Lebman, and S. Spiegel Cross-talk at the crossroads of sphingosine-1-phosphate, growth factors, and cytokine signaling J. Lipid Res. 49 2008 1388 1394
55. G.M. Strub, M. Maceyka, N.C. Hait, S. Milstien, and S. Spiegel Extracellular and intracellular actions of sphingosine-1-phosphate Adv. Exp. Med. Biol. 688 2010 141 155
56. T. Hla, K. Venkataraman, and J. Michaud The vascular S1P gradient-cellular sources and biological significance Biochim. Biophys. Acta 1781 2008 477 482
57. S. Selim, M. Sunkara, A.K. Salous, S.W. Leung, E.V. Berdyshev, A. Bailey, C.L. Campbell, R. Charnigo, A.J. Morris, and S.S. Smyth Plasma levels of sphingosine 1-phosphate are strongly correlated with haematocrit, but variably restored by red blood cell transfusions Clin. Sci. (Lond.) 121 2011 565 572
58. T. Ulrych, A. Bohm, A. Polzin, G. Daum, R.M. Nusing, G. Geisslinger, T. Hohlfeld, K. Schror, and B.H. Rauch Release of sphingosine-1-phosphate from human platelets is dependent on thromboxane formation J. Thromb. Haemost. 9 2011 790 798
59. C. Christoffersen, H. Obinata, S.B. Kumaraswamy, S. Galvani, J. Ahnstrom, M. Sevvana, C. Egerer-Sieber, Y.A. Muller, T. Hla, L.B. Nielsen, and B. Dahlback Endothelium-protective sphingosine-1-phosphate provided by HDL-associated apolipoprotein M Proc. Natl. Acad. Sci. U. S. A. 108 2011 9613 9618
60. S. Spiegel, and S. Milstien Functions of a new family of sphingosine-1-phosphate receptors Biochim. Biophys. Acta 1484 2000 107 116
61. S. An, E.J. Goetzl, and H. Lee Signaling mechanisms and molecular characteristics of G protein-coupled receptors for lysophosphatidic acid and sphingosine 1-phosphate J. Cell. Biochem. 30-31 1998 147 157 (Supplement)
62. W.H. Moolenaar Bioactive lysophospholipids and their G protein-coupled receptors Exp. Cell Res. 253 1999 230 238
63. M.C. Michel, A.C. Mulders, M. Jongsma, A.E. Alewijnse, and S.L. Peters Vascular effects of sphingolipids Acta Paediatr. Suppl. 96 2007 44 48
64. 2 + mobilization, Ras-mitogen-activated protein kinase activation, and adenylate cyclase inhibition J. Biol. Chem. 273 1998 27104 27110
65. J.H. Paik, S. Chae, M.J. Lee, S. Thangada, and T. Hla Sphingosine 1-phosphate-induced endothelial cell migration requires the expression of EDG-1 and EDG-3 receptors and Rho-dependent activation of alpha vbeta3- and beta1-containing integrins J. Biol. Chem. 276 2001 11830 11837
66. N. Sugimoto, N. Takuwa, H. Okamoto, S. Sakurada, and Y. Takuwa Inhibitory and stimulatory regulation of Rac and cell motility by the G12/13-Rho and Gi pathways integrated downstream of a single G protein-coupled sphingosine-1-phosphate receptor isoform Mol. Cell. Biol. 23 2003 1534 1545
67. W. Du, N. Takuwa, K. Yoshioka, Y. Okamoto, K. Gonda, K. Sugihara, A. Fukamizu, M. Asano, and Y. Takuwa S1P(2), the G protein-coupled receptor for sphingosine-1-phosphate, negatively regulates tumor angiogenesis and tumor growth in vivo in mice Cancer Res. 70 2010 772 781
68. G.C. Zondag, F.R. Postma, I.V. Etten, I. Verlaan, and W.H. Moolenaar Sphingosine 1-phosphate signalling through the G-protein-coupled receptor Edg-1 Biochem. J. 330 Pt 2 1998 605 609
69. R.T. Windh, M.J. Lee, T. Hla, S. An, A.J. Barr, and D.R. Manning Differential coupling of the sphingosine 1-phosphate receptors Edg-1, Edg-3, and H218/Edg-5 to the G(i), G(q), and G(12) families of heterotrimeric G proteins J. Biol. Chem. 274 1999 27351 27358
70. Y. Takuwa, W. Du, X. Qi, Y. Okamoto, N. Takuwa, and K. Yoshioka Roles of sphingosine-1-phosphate signaling in angiogenesis World J. Biol. Chem. 1 2010 298 306
71. K. Sato, J. Kon, H. Tomura, M. Osada, N. Murata, A. Kuwabara, T. Watanabe, H. Ohta, M. Ui, and F. Okajima Activation of phospholipase C-Ca2 + system by sphingosine 1-phosphate in CHO cells transfected with Edg-3, a putative lipid receptor FEBS Lett. 443 1999 25 30
72. H. Okamoto, N. Takuwa, T. Yokomizo, N. Sugimoto, S. Sakurada, H. Shigematsu, and Y. Takuwa Inhibitory regulation of Rac activation, membrane ruffling, and cell migration by the G protein-coupled sphingosine-1-phosphate receptor EDG5 but not EDG1 or EDG3 Mol. Cell. Biol. 20 2000 9247 9261
73. I. Ishii, B. Friedman, X. Ye, S. Kawamura, C. McGiffert, J.J. Contos, M.A. Kingsbury, G. Zhang, J.H. Brown, and J. Chun Selective loss of sphingosine 1-phosphate signaling with no obvious phenotypic abnormality in mice lacking its G protein-coupled receptor, LP(B3)/EDG-3 J. Biol. Chem. 276 2001 33697 33704
74. Y. Liu, R. Wada, T. Yamashita, Y. Mi, C.X. Deng, J.P. Hobson, H.M. Rosenfeldt, V.E. Nava, S.S. Chae, M.J. Lee, C.H. Liu, T. Hla, S. Spiegel, and R.L. Proia Edg-1, the G protein-coupled receptor for sphingosine-1-phosphate, is essential for vascular maturation J. Clin. Invest. 106 2000 951 961
75. M.L. Allende, T. Yamashita, and R.L. Proia G-protein-coupled receptor S1P1 acts within endothelial cells to regulate vascular maturation Blood 102 2003 3665 3667
76. M. Kono, I.A. Belyantseva, A. Skoura, G.I. Frolenkov, M.F. Starost, J.L. Dreier, D. Lidington, S.S. Bolz, T.B. Friedman, T. Hla, and R.L. Proia Deafness and stria vascularis defects in S1P2 receptor-null mice J. Biol. Chem. 282 2007 10690 10696
77. I. Inoki, N. Takuwa, N. Sugimoto, K. Yoshioka, S. Takata, S. Kaneko, and Y. Takuwa Negative regulation of endothelial morphogenesis and angiogenesis by S1P2 receptor Biochem. Biophys. Res. Commun. 346 2006 293 300
78. M. Kono, Y. Mi, Y. Liu, T. Sasaki, M.L. Allende, Y.P. Wu, T. Yamashita, and R.L. Proia The sphingosine-1-phosphate receptors S1P1, S1P2, and S1P3 function coordinately during embryonic angiogenesis J. Biol. Chem. 279 2004 29367 29373
79. E. Camerer, J.B. Regard, I. Cornelissen, Y. Srinivasan, D.N. Duong, D. Palmer, T.H. Pham, J.S. Wong, R. Pappu, and S.R. Coughlin Sphingosine-1- phosphate in the plasma compartment regulates basal and inflammation-induced vascular leak in mice J. Clin. Invest. 119 2009 1871 1879
80. T. Sanchez, T. Estrada-Hernandez, J.H. Paik, M.T. Wu, K. Venkataraman, V. Brinkmann, K. Claffey, and T. Hla Phosphorylation and action of the immunomodulator FTY720 inhibits vascular endothelial cell growth factor-induced vascular permeability J. Biol. Chem. 278 2003 47281 47290
81. X. Peng, P.M. Hassoun, S. Sammani, B.J. McVerry, M.J. Burne, H. Rabb, D. Pearse, R.M. Tuder, and J.G. Garcia Protective effects of sphingosine 1-phosphate in murine endotoxin-induced inflammatory lung injury Am. J. Respir. Cri.t Care Med. 169 2004 1245 1251
82. B.J. McVerry, X. Peng, P.M. Hassoun, S. Sammani, B.A. Simon, and J.G. Garcia Sphingosine 1-phosphate reduces vascular leak in murine and canine models of acute lung injury Am. J. Respir. Cri.t Care Med. 170 2004 987 993
83. M.G. Sanna, S.K. Wang, P.J. Gonzalez-Cabrera, A. Don, D. Marsolais, M.P. Matheu, S.H. Wei, I. Parker, E. Jo, W.C. Cheng, M.D. Cahalan, C.H. Wong, and H. Rosen Enhancement of capillary leakage and restoration of lymphocyte egress by a chiral S1P1 antagonist in vivo Nat. Chem. Biol. 2 2006 434 441
84. B.S. Shea, S.F. Brooks, B.A. Fontaine, J. Chun, A.D. Luster, and A.M. Tager Prolonged exposure to sphingosine 1-phosphate receptor-1 agonists exacerbates vascular leak, fibrosis, and mortality after lung injury Am. J. Respir. Cell Mol. Biol. 43 2010 662 673
85. G. Bazzoni, and E. Dejana Endothelial cell-to-cell junctions: molecular organization and role in vascular homeostasis Physiol. Rev. 84 2004 869 901
86. I. Grosheva, M. Shtutman, M. Elbaum, and A.D. Bershadsky p120 catenin affects cell motility via modulation of activity of Rho-family GTPases: a link between cell-cell contact formation and regulation of cell locomotion J. Cell Sci. 114 2001 695 707
87. S.J. Arnold, J. Stappert, A. Bauer, A. Kispert, B.G. Herrmann, and R. Kemler Brachyury is a target gene of the Wnt/beta-catenin signaling pathway Mech. Dev. 91 2000 249 258
88. J.O. Humtsoe, M. Liu, A.B. Malik, and K.K. Wary Lipid phosphate phosphatase 3 stabilization of beta-catenin induces endothelial cell migration and formation of branching point structures Mol. Cell. Biol. 30 2010 1593 1606
89. J.O. Humtsoe, R.A. Bowling Jr., S. Feng, and K.K. Wary Murine lipid phosphate phosphohydrolase-3 acts as a cell-associated integrin ligand Biochem. Biophys. Res. Commun. 335 2005 906 919
90. M. Kai, I. Wada, S. Imai, F. Sakane, and H. Kanoh Identification and cDNA cloning of 35-kDa phosphatidic acid phosphatase (type 2) bound to plasma membranes. Polymerase chain reaction amplification of mouse H2O2-inducible hic53 clone yielded the cDNA encoding phosphatidic acid phosphatase J. Biol. Chem. 271 1996 18931 18938
91. Y.J. Jia, M. Kai, I. Wada, F. Sakane, and H. Kanoh Differential localization of lipid phosphate phosphatases 1 and 3 to cell surface subdomains in polarized MDCK cells FEBS Lett. 552 2003 240 246
92. J.O. Humtsoe, S. Feng, G.D. Thakker, J. Yang, J. Hong, and K.K. Wary Regulation of cell-cell interactions by phosphatidic acid phosphatase 2b/VCIP EMBO J. 22 2003 1539 1554
93. K.K. Wary, and J.O. Humtsoe Anti-lipid phosphate phosphohydrolase-3 (LPP3) antibody inhibits bFGF- and VEGF-induced capillary morphogenesis of endothelial cells Cell Commun. Signal. 3 2005 9
94. H. Schunkert, I.R. Konig, S. Kathiresan, M.P. Reilly, T.L. Assimes, H. Holm, M. Preuss, A.F. Stewart, M. Barbalic, C. Gieger, D. Absher, Z. Aherrahrou, H. Allayee, D. Altshuler, S.S. Anand, K. Andersen, J.L. Anderson, D. Ardissino, S.G. Ball, A.J. Balmforth, T.A. Barnes, D.M. Becker, L.C. Becker, K. Berger, J.C. Bis, S.M. Boekholdt, E. Boerwinkle, P.S. Braund, M.J. Brown, M.S. Burnett, I. Buysschaert, J.F. Carlquist, L. Chen, S. Cichon, V. Codd, R.W. Davies, G. Dedoussis, A. Dehghan, S. Demissie, J.M. Devaney, P. Diemert, R. Do, A. Doering, S. Eifert, N.E. Mokhtari, S.G. Ellis, R. Elosua, J.C. Engert, S.E. Epstein, U. de Faire, M. Fischer, A.R. Folsom, J. Freyer, B. Gigante, D. Girelli, S. Gretarsdottir, V. Gudnason, J.R. Gulcher, E. Halperin, N. Hammond, S.L. Hazen, A. Hofman, B.D. Horne, T. Illig, C. Iribarren, G.T. Jones, J.W. Jukema, M.A. Kaiser, L.M. Kaplan, J.J. Kastelein, K.T. Khaw, J.W. Knowles, G. Kolovou, A. Kong, R. Laaksonen, D. Lambrechts, K. Leander, G. Lettre, M. Li, W. Lieb, C. Loley, A.J. Lotery, P.M. Mannucci, S. Maouche, N. Martinelli, P.P. McKeown, C. Meisinger, T. Meitinger, O. Melander, P.A. Merlini, V. Mooser, T. Morgan, T.W. Muhleisen, J.B. Muhlestein, T. Munzel, K. Musunuru, J. Nahrstaedt, C.P. Nelson, M.M. Nothen, O. Olivieri, R.S. Patel, C.C. Patterson, A. Peters, F. Peyvandi, L. Qu, A.A. Quyyumi, D.J. Rader, L.S. Rallidis, C. Rice, F.R. Rosendaal, D. Rubin, V. Salomaa, M.L. Sampietro, M.S. Sandhu, E. Schadt, A. Schafer, A. Schillert, S. Schreiber, J. Schrezenmeir, S.M. Schwartz, D.S. Siscovick, M. Sivananthan, S. Sivapalaratnam, A. Smith, T.B. Smith, J.D. Snoep, N. Soranzo, J.A. Spertus, K. Stark, K. Stirrups, M. Stoll, W.H. Tang, S. Tennstedt, G. Thorgeirsson, G. Thorleifsson, M. Tomaszewski, A.G. Uitterlinden, A.M. van Rij, B.F. Voight, N.J. Wareham, G.A. Wells, H.E. Wichmann, P.S. Wild, C. Willenborg, J.C. Witteman, B.J. Wright, S. Ye, T. Zeller, A. Ziegler, F. Cambien, A.H. Goodall, L.A. Cupples, T. Quertermous, W. Marz, C. Hengstenberg, S. Blankenberg, W.H. Ouwehand, A.S. Hall, P. Deloukas, J.R. Thompson, K. Stefansson, R. Roberts, U. Thorsteinsdottir, C.J. O'Donnell, R. McPherson, J. Erdmann, and N.J. Samani Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease Nat. Genet. 43 2011 333 338
95. M. Olivier From SNPs to function: the effect of sequence variation on gene expression. Focus on a survey of genetic and epigenetic variation affecting human gene expression Physiol. Genomics 16 2004 182 183
96. T.A. Greenwood, and J.R. Kelsoe Promoter and intronic variants affect the transcriptional regulation of the human dopamine transporter gene Genomics 82 2003 511 520
97. Y. Zhang, A. Bertolino, L. Fazio, G. Blasi, A. Rampino, R. Romano, M.L. Lee, T. Xiao, A. Papp, D. Wang, and W. Sadee Polymorphisms in human dopamine D2 receptor gene affect gene expression, splicing, and neuronal activity during working memory Proc. Natl. Acad. Sci. U. S. A. 104 2007 20552 20557
98. G.S. Wang, and T.A. Cooper Splicing in disease: disruption of the splicing code and the decoding machinery Nat. Rev. Genet. 8 2007 749 761